Exposure to polychlorinated biphenyl-153 decreases incidence of autoimmune Type 1 diabetes in non-obese diabetic mice

Journal of Immunotoxicology

Volumn 13, Issue 6, 2016, Pages 850-860

  Kuiper, Jordan ^a   Moran, Michelle ^a   Cetkovic Cvrlje, Marina ^a  

^a ST CLOUD STATE UNIVERSITY   (United States)

Author keywords

Diabetes; non obese diabetic mice; PCB 153; persistent organic pollutants; T cells; Type 1 diabetes

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; 2,4,5,2',4',5'-HEXACHLOROBIPHENYL; CYTOKINE; POLLUTANT; POLYCHLORINATED BIPHENYL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; CELL CULTURE; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; HUMAN; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; POLLUTANT;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENVIRONMENTAL POLLUTANTS; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MICE; MICE, INBRED NOD; MODELS, ANIMAL; POLYCHLORINATED BIPHENYLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84986237305     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.1080/1547691X.2016.1213333     Document Type: Article

References (46)

1. Beineke A, Siebert U, McLachlan M, Bruhn R, Thron K, Failing K, Müller G, Baumgärtner W., 2005. Investigations of the potential influence of environmental contaminants on the thymus and spleen of harbor porpoises (Phocoena phocoena). Environ Sci Technol. 39:3933–3938.
2. Bodin J, Bølling AK, Becher R, Kuper F, Løvik M, Nygaard UC., 2014. Trans-maternal bisphenol A exposure accelerates diabetes Type 1 development in NOD mice. Toxicol Sci. 137:311–323.
3. Bodin J, Bølling AK, Samuelsen M, Becher R, Løvik M, Nygaard UC., 2013. Long-term bisphenol A exposure accelerates insulitis development in diabetes-prone NOD mice. Immunopharmacol Immunotoxicol. 35:349–358.
4. Bodin J, Stene LC, Nygaard UC., 2015. Can exposure to environmental chemicals increase the risk of diabetes Type 1 development? Biomed Res Int. 2015:208947.
5. Cetkovic-Cvrlje M, Dragt AL, Vassiley A, Liu XP, Uckun FM., 2003. Targeting JAK3 with JANEX-1 for prevention of autoimmune Type 1 diabetes in NOD mice. Clin Immunol. 106:213–225.
6. Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliot JF, Leiter EH., 1997. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intra-thymic administration of candidate β cell antigens. Diabetes. 46:1975–1982.
7. Cetkovic-Cvrlje M, Olson M, Ghate K., 2012. Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells. Cell Mol Immunol. 9:350–360.
8. Cetkovic-Cvrlje M, Olson M, Schindler B, Gong HK., 2015. Exposure to DDT metabolite p,p′-DDE increases autoimmune Type 1 diabetes incidence in NOD mouse model. J Immunotoxicol. 13:108–118.
9. Cetkovic-Cvrlje M, Roers BA, Schonhoff D, Waurzyniak B, Liu XP, Uckun FM., 2002. Treatment of post-bone marrow transplant acute graft-versus-host disease with a rationally designed JAK3 inhibitor. Leuk Lymphoma. 43:1447–1453.
10. Cetkovic-Cvrlje M, Roers BA, Waurzyniak B, Liu XP, Uckun FM., 2001. Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice. Blood. 98:1607–1613.
11. Cetkovic-Cvrlje M, Uckun FM., 2004. Dual targeting of Bruton’s tyrosine kinase and JAK3 with rationally designed inhibitors prevents graft-vs.-host disease (GVHD) in a murine allogeneic bone marrow transplantation model. Br J Haematol. 126:821–827.
12. Cetkovic-Cvrlje M, Uckun FM., 2005. Effect of targeted disruption of signal transducer and activator of transcription (Stat)4 and Stat6 genes on the autoimmune diabetes development induced by multiple low doses of streptozotocin. Clin Immunol. 114:299–306.
13. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, et al. 2014. Prevalence of Type 1 and Type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 311:1778–1786.
14. Duffy-Whritenour JE, Kurtzman RZ, Kennedy S, Zelikoff JT., 2010. Non-coplanar polychlorinated biphenyl (PCB)-induced immunotoxicity is coincident with alterations in the serotonergic system. J Immunotoxicol. 7:318–326.
15. EMEP/CORINAIR Guidebook. 2005. EMEP/EEA sources of PCB emissions [Internet]; [cited 2016 May 25]. Available from:http://www.eea.europa.eu.
16. Environmental Protection Agency. 2009. Persistent organic pollutants:a global issue, a global response [Internet]; [cited 2016 May 25]. Available from:http://www.epa.gov/oia/toxics/pop.html.
17. Fischer LJ, Wagner MA, Madhukar BV., 1999. Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol. 159:194–203.
18. H2 differentiation. Immunopharmacol Immunotoxicol. 34:627–632.
19. Glynn A, Thuvander A, Aune M, Johannisson A, Darnerud PO, Ronquist G, Cnattingius S., 2008. Immune cell counts and risks of respiratory infections among infants exposed pre- and postnatally to organochlorine compounds:a prospective study. Environ Health. 7:62.
20. Hong J, Yu S, Ahn J, Kim S, Kim G, Kim Y, Son S, Hwang S., 2016. Environmental risk assessment of toxicity exposure:high-throughput expression profiling. Biochip J. 10:74–80.
21. Hulme MA, Wasserfall CH, Atkinson MA, Brusko TM., 2012. Central role for interleukin-2 in Type 1 diabetes. Diabetes. 61:14–22.
22. Knip M, Simell O., 2012. Environmental triggers of Type 1 diabetes. Cold Spring Harb Perspect Med. 2:a007690.
23. Langer P, Tajtakova M, Guretzki HJ, Kocan A, Petrik J, Chovancova J, Drobná B, Jursa S, Pavúk M, Trnovec T, et al. 2002. High prevalence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in employees at a polychlorinated biphenyl production factory. Arch Environ Health. 57:412–415.
24. Lecavalier P, Chu I, Yagminas A, Villeneuve DC, Poon R, Feeley M, Håkansson H, Ahlborg UG, Valli VE, Bergman A, et al. 1997. Subchronic toxicity of 2,2′,3,3′,4,4′-hexachlorobiphenyl in rats. J Toxicol Environ Health. 51:265–277.
25. Lee D, Steffes M, Jacobs D., 2007. Positive associations of serum concentration of poly-chlorinated biphenyls and organochlorine pesticides with self-reported arthritis; especially rheumatoid type, in women. Environ Health Perspect. 115:883–888.
26. Leijs M, Koppe J, Olie K, Van Aalderen M, de Voogt P, Ten Tusscher G., 2009. Effects of dioxins, PCBs, and PBDEs on immunology and hematology in adolescents. Environ Sci Technol. 43:7946–7951.
27. Li MH, Tsai P, Hseih C, Guo YL, Rogan WJ, 2013. Mortality after exposure to polychlorinated dibenzofurans:30 years after the “Yucheng Accident”. Environ Res. 120:71–75.
28. Longnecker MP, Daniels JL., 2001. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect. 19:871–876.
29. Lu YC, Wu YC., 1985. Clinical findings and immunological abnormalities in Yu Cheng patients. Environ Health Perspect. 59:17–29.
30. Milan M, Pauletto M, Boffo L, Sorrentino F, Ferrari G, Pavan L, Patarnello T, Bargelloni L., 2015. Transcriptomic resources for environmental risk assessment:a case study in the Venice lagoon. Environ Pollut. 197:90–98.
31. NTP [National Toxicology Program]. 2006. Technical report on toxicology and carcinogenesis studies of 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage Studies). NIH Publication no. 06-4465 [Internet]; [cited 2016 May 25]. Available from:http://ntp.niehs.nih.gov/results/pubs/longterm/reports/longterm/tr500580/listedreports/tr529/index.html.
32. Rignell-Hydbom A, Elfving M, Ivarsson SA, Lindh C, Jönsson BAG, Olofsson P, Rylander L., 2010. A nested case–control study of intrauterine exposure to persistent organochlorine pollutants in relation to risk of Type 1 diabetes. PLoS One. 5:e11281.
33. Ropstad E, Oskam I, Lyche J, Larsen H, Lie E, Haave M, Dahl E, Wiger R, Skaare J., 2006. Endocrine disruption induced by organochlorines (OCs):field studies and experimental models. J Toxicol Environ Health Part A. 69:53–76.
34. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, et al. 2005. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity. 23:115–126.
35. H cell polarization and its relevance in Type 1 diabetes mellitus. Rev Diabet Stud. 2:182–186.
36. Smialowicz RJ, Devito MJ, Riddle MM, Williams WC, Birnbaum LS., 1997. Opposite effects of 2,2′,4,4′,5,5′-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice. Fundam Appl Toxicol. 37:141–149.
37. Steppan L, DeKrey G, Fowles J, Kerkvliet NI., 1993. Polychlorinated biphenyl (PCB) induced alteration in cytokine profile in peritoneal cavity of mice during course of P815 tumor rejection. J Immunol. 150:134A.
38. Strathmann J, Schwarz M, Tharappel JC, Glauert HP, Spear BT, Robertson LW, Appel KE, Buchmann A., 2006. PCB 153, a non-dioxin–like tumor promoter, selects for b-catenin (catnb)–mutated mouse liver tumors. Toxicol Sci. 93:34–40.
39. Tan Y, Li D, Song R, Lawrence D, Carpenter D., 2003. Ortho-substituted PCBs kill thymocytes. Toxicol Sci. 76:328–337.
40. Tang M, Chen K, Yang F, Liu W., 2014. Exposure to organochlorine pollutants and Type 2 diabetes:a systematic review and meta-analysis. PLoS One. 9:e85556.
41. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, DeVito M, Jacobs D, Köhrle J, Lee DH, Rylander L, et al. 2013. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies:a national toxicology program workshop review. Environ Health Perspect. 121:774–783.
42. Tryphonas H., 1995. Immunotoxicity of PCBs (Aroclor) in relation to Great Lakes. Environ Health Perspect. 103:35–46.
43. Tsai PC, Ko YC, Huang W, Liu HS, Guo YL., 2007. Increased liver and lupus mortalities in 24-yr follow-up of Taiwanese people highly exposed to polychlorinated biphenyls and dibenzo-furans. Sci Total Environ. 374:216–222.
44. Uno S, Imagawa A, Okita K, Sayama K, Moriwaki M, Iwahashi H, Yamagata K, Tamura S, Matsuzawa Y, Hanafusa T, et al. 2007. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset Type 1 diabetes. Diabetologia. 50:596–601.
45. Weisglas-Kuperus N, Patandin S, Berbers GAM, Sas TCJ, Mulder PGH, Sauer PJJ, Hooljkaas H., 2000. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect. 108:1203–1207.
46. World Health Organization. 2008. Training for the health sector–persistent organic pollutants–Children’s health and the environment [Internet]; [cited 2016 May 25]. Available from:http://www.who.int/ceh/capacity/POPs.pdf.